Table 3.

Percentage (%) of amoebae adhesion reduction (AR) ± standard deviation (SD) after incubation with tested agents depending on the FDA type of contact lenses used.

	FDA 1	FDA 2	FDA 3	FDA 4
SCA	17.61 ± 3.69	no activity	21.47 ± 16.83	23.47 ± 41.59
SCA + 1.25 ppm AgTANPs	46.31 ± 1.55	26.58 ± 41.44	26.79 ± 26.79	17.33 ± 1.47
SCA + 2.5 ppm AgTANPs	76.61 ± 11.99	69.64 ± 20.95	26.12 ± 53.77	39.52 ± 12.25
SCA + 5 ppm AgTANPs	93.25 ± 5.51	70.22 ± 23.66	30.21 ± 30.65	91.88 ± 4.68
SCA + 10 ppm AgTANPs	96.86 ± 0.47	70.51 ± 8.57	89.24 ± 6.75	86.60 ± 14.37
O-F	no activity	4.28 ± 20.95	no activity	36.52 ± 27
O-F + 1.25 ppm AgTANPs	no activity	60.86 ± 31.18	no activity	33.56 ± 35.88
O-F + 2.5 ppm AgTANPs	88.46 ± 10.27	88.28 ± 9.49	no activity	88.66 ± 3.55
O-F + 5 ppm AgTANPs	83.16 ± 4.94	99.79 ± 0.19	49.16 ± 16.42	97.15 ± 0.39
O-F + 10 ppm AgTANPs	89.24 ± 7.57	100	80.93 ± 4.96	98.83 ± 0.49
ReNu	no activity	14.99 ± 10.53	22.46 ± 4.27	no activity
RenNu + 1.25 ppm AgTANPs	27.82 ± 46.06	34.03 ± 15.06	42.64 ± 15.32	no activity
ReNu + 2.5 ppm AgTANPs	48.99 ± 34.85	38.09 ± 9.06	42.64 ± 5.74	no activity
ReNu + 5 ppm AgTANPs	89.85 ± 0.86	65.58 ± 19.18	48.08 ± 26.44	50.21 ± 7.87
ReNu + 10 ppm AgTANPs	92.99 ± 3.43	82.16 ± 3.06	78.96 ± 7.51	69.77 ± 17.01